BACKGROUND: More than half of the cells in the brain are glia and yet the impact of general anaesthetics on these cells is largely unexamined. We hypothesized that astroglia, which are strongly implicated in neuronal well-being and synapse formation and function, are vulnerable to adverse effects of isoflurane. METHODS: Cultured rat astrocytes were treated with 1.4% isoflurane in air or air alone for 4 h. Viability, proliferation, and cytoskeleton were assessed by colorimetric assay, immunocytochemistry, or a migration assay at the end of treatment or 2 days later. Also, primary rat cortical neurones were treated for 4 days with conditioned medium from control [astrocyte-conditioned media (ACM)], or isoflurane-exposed astrocytes (Iso-ACM) and synaptic puncta were assessed by synapsin 1 and PSD-95 immunostaining. RESULTS: By several measures, isoflurane did not kill astrocytes. Nor, based on incorporation of a thymidine analogue, did it inhibit proliferation. Isoflurane had no effect on F-actin but reduced expression of α-tubulin and glial fibrillary acidic protein both during exposure (P<0.05 and P<0.001, respectively) and 2 days later (P<0.01), but did not impair astrocyte motility. ACM increased formation of PSD-95 but not synapsin 1 positive puncta in neuronal cultures, and Iso-ACM was equally effective. CONCLUSIONS: Isoflurane decreased expression of microtubule and intermediate filament proteins in astrocytes in vitro, but did not affect their viability, proliferation, motility, and ability to support synapses.
BACKGROUND: More than half of the cells in the brain are glia and yet the impact of general anaesthetics on these cells is largely unexamined. We hypothesized that astroglia, which are strongly implicated in neuronal well-being and synapse formation and function, are vulnerable to adverse effects of isoflurane. METHODS: Cultured rat astrocytes were treated with 1.4% isoflurane in air or air alone for 4 h. Viability, proliferation, and cytoskeleton were assessed by colorimetric assay, immunocytochemistry, or a migration assay at the end of treatment or 2 days later. Also, primary rat cortical neurones were treated for 4 days with conditioned medium from control [astrocyte-conditioned media (ACM)], or isoflurane-exposed astrocytes (Iso-ACM) and synaptic puncta were assessed by synapsin 1 and PSD-95 immunostaining. RESULTS: By several measures, isoflurane did not kill astrocytes. Nor, based on incorporation of a thymidine analogue, did it inhibit proliferation. Isoflurane had no effect on F-actin but reduced expression of α-tubulin and glial fibrillary acidic protein both during exposure (P<0.05 and P<0.001, respectively) and 2 days later (P<0.01), but did not impair astrocyte motility. ACM increased formation of PSD-95 but not synapsin 1 positive puncta in neuronal cultures, and Iso-ACM was equally effective. CONCLUSIONS:Isoflurane decreased expression of microtubule and intermediate filament proteins in astrocytes in vitro, but did not affect their viability, proliferation, motility, and ability to support synapses.
Authors: Hugh C Hemmings; Myles H Akabas; Peter A Goldstein; James R Trudell; Beverley A Orser; Neil L Harrison Journal: Trends Pharmacol Sci Date: 2005-10 Impact factor: 14.819
Authors: Vesna Jevtovic-Todorovic; Richard E Hartman; Yukitoshi Izumi; Nicholas D Benshoff; Krikor Dikranian; Charles F Zorumski; John W Olney; David F Wozniak Journal: J Neurosci Date: 2003-02-01 Impact factor: 6.167
Authors: Anna V Molofsky; Robert Krencik; Robert Krenick; Erik M Ullian; Erik Ullian; Hui-hsin Tsai; Benjamin Deneen; William D Richardson; Ben A Barres; David H Rowitch Journal: Genes Dev Date: 2012-05-01 Impact factor: 11.361
Authors: Ana Lucía Rodríguez-Perea; Johanna Gutierrez-Vargas; Gloria Patricia Cardona-Gómez; Carlos Julio Montoya Guarin; Mauricio Rojas; Paula Andrea Velilla Hernández Journal: J Neuroimmune Pharmacol Date: 2016-09-10 Impact factor: 4.147
Authors: V Jevtovic-Todorovic; A R Absalom; K Blomgren; A Brambrink; G Crosby; D J Culley; G Fiskum; R G Giffard; K F Herold; A W Loepke; D Ma; B A Orser; E Planel; W Slikker; S G Soriano; G Stratmann; L Vutskits; Z Xie; H C Hemmings Journal: Br J Anaesth Date: 2013-05-30 Impact factor: 9.166